D-galactosamine (GalN) is a highly selective hepatotoxin that causes liver damage similar to human viral hepatitis via depletion of uridine nucleotides, which subsequently diminishes synthesis of RNA and proteins. Model of galactosamine hepatotoxicity is frequently used in animal experiments in vitro. The purpose of our study was to establish the model of GalN-induced hepatocyte injury in in vitro conditions using primocultures of rat hepatocytes as an important prerequisite for further experiments in which we would like to study potential hepatoprotective effect of various substances. Rate of hepatocyte injury was evaluated by morphological changes, changes in cell viability, albumin production, mitochondrial membrane potential, activity o...
Galactosamine (galN) is widely used as an <i>in vivo</i> model of acute liver injury. We have applie...
A reproducible animal model of fulminant hepatic failure was developed by intraperitoneal administra...
Galactosamine (GalN) is a well-known agent for inducing viral hepatitis models in rodents, but it ca...
Background: Short-term administration of Galactosamine to experimental animals causes liver damage a...
Sensitivity to galactosamine (GALN) of normal liver, carcinogen-induced preneoplastic liver and hepa...
ABSTRACT PURPOSE: To describe an animal model for acute liver failure by intraperitoneal d-galacto...
Objective: This study was done to clarify the effect of high dose of D-Galactosamine (GalN) on oxida...
Background: Compared with biofluids, target tissues and organs more directly reflect the pathophysio...
Liver damage has a variety of causes. Due to the role of liver in the metabolism of xenobiotics, liv...
It has been shown that hepatocytes cultured in a collagen sandwich configuration maintain cell viabi...
Background: Cell death pathway can occur under physiological or pathological conditions. In vitro an...
Extrahepatic factors, such as increased gut permeability and bacteria from the gut, have been shown ...
Galactosamine induces a dose-dependent hepatic injury in rats and many other animals. The toxicity o...
AbstractBackground: Cell death pathway can occur under physiological or pathological conditions. In ...
BACKGROUND & AIMS\ud \ud Metabolomics is comprehensive analysis of low-molecular-weight endogenous m...
Galactosamine (galN) is widely used as an <i>in vivo</i> model of acute liver injury. We have applie...
A reproducible animal model of fulminant hepatic failure was developed by intraperitoneal administra...
Galactosamine (GalN) is a well-known agent for inducing viral hepatitis models in rodents, but it ca...
Background: Short-term administration of Galactosamine to experimental animals causes liver damage a...
Sensitivity to galactosamine (GALN) of normal liver, carcinogen-induced preneoplastic liver and hepa...
ABSTRACT PURPOSE: To describe an animal model for acute liver failure by intraperitoneal d-galacto...
Objective: This study was done to clarify the effect of high dose of D-Galactosamine (GalN) on oxida...
Background: Compared with biofluids, target tissues and organs more directly reflect the pathophysio...
Liver damage has a variety of causes. Due to the role of liver in the metabolism of xenobiotics, liv...
It has been shown that hepatocytes cultured in a collagen sandwich configuration maintain cell viabi...
Background: Cell death pathway can occur under physiological or pathological conditions. In vitro an...
Extrahepatic factors, such as increased gut permeability and bacteria from the gut, have been shown ...
Galactosamine induces a dose-dependent hepatic injury in rats and many other animals. The toxicity o...
AbstractBackground: Cell death pathway can occur under physiological or pathological conditions. In ...
BACKGROUND & AIMS\ud \ud Metabolomics is comprehensive analysis of low-molecular-weight endogenous m...
Galactosamine (galN) is widely used as an <i>in vivo</i> model of acute liver injury. We have applie...
A reproducible animal model of fulminant hepatic failure was developed by intraperitoneal administra...
Galactosamine (GalN) is a well-known agent for inducing viral hepatitis models in rodents, but it ca...